Chemical Structure (Journavx 01)
Journavx Tablet, Film Coated
Product Images NDC 51167-548
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Journavx (NDC 51167-548). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Vertex Pharmaceuticals Incorporated, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure 1 (Journavx 02)
Mean NPRS data related to Placebo and HB/APAP intervention over time in hours. This information can be used to analyze and compare the pain levels experienced by subjects in the study.*
Figure 2 (Journavx 03)
This text shows a table displaying the mean NPRS (numeric pain rating scale) for different treatments at various time intervals. The treatments include Placebo and HB/APAP. The table also lists the time intervals in hours. This information can be useful for comparing the effectiveness of the Placebo and HB/APAP treatments in pain management over time.*
Principal Display Panel (50 mg Tablet Bottle Label)
Principal Display Panel (50 mg Tablet Bottle Label)
This text contains information about a product that includes 100 tablets for oral use. It also provides guidance to refer to the prescribing information for recommended dosage. The location mentioned is Ave, Boston, MA 02210.*
Principal Display Panel (50 mg Tablet Blister Pack Carton)
This text appears to be a description of a pharmaceutical product named "JOURNAVX" (suzetrigine) tablets in unit dose packaging. The tablets are for institutional use only and come in a pack of 100 tablets. The product is prescription-only and has a National Drug Code (NDC) of 51167-5648-34. The text also includes some identification numbers and codes related to the product.*
Principal Display Panel (50 mg Tablet Blister Pack Carton)
This is a description for JOURNAVX tablets in 50 mg per tablet strength. It is a professional sample and not for sale. The tablets contain suzetrigine as the active ingredient.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
